Drugs / HP515
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07308548 | Oct 2025 → Aug 2026 overdue | NAFLD1 | Hinova Pharmaceuticals Inc. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HP515 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07308548 ↗ |